Live Breaking News & Updates on Groupc Monthly

Stay updated with breaking news from Groupc monthly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Leick on Limitations Associated With CAR T-Cell Therapy in Hematologic Malignancies

Mark Leick, MD, discusses the challenges and limitations associated with the use of CAR T-cell therapy across hematologic malignancies, highlighting how ongoing research may potentially ameliorate present unmet needs. ....

United States , Mark Leick , Research Institute , Groupc Monthly , Harvard Medical School , Stanford University , Massachusetts General Research Institute , Massachusetts General Hospital , Cart Cell Therapy , B Cell Lymphoma , Elderly Or Frail Patients ,

Dr Leick on the Use of CAR T-Cell Therapy Across Hematologic Malignancies

Mark Leick, MD, discusses the varying role of CAR T-cell therapy across various hematologic malignancies, elaborating on the cause of its effectiveness in these disease spaces.
....

United States , Mark Leick , Groupc Monthly , Research Institute , Harvard Medical School , Massachusetts General Research Institute , Massachusetts General Hospital , Cart Cell Therapy , B Cell Lymphoma , Elderly Or Frail Patients ,

Research Remains Focused on Bringing CAR T-Cell Therapy to Solid Tumors

Mark Leick, MD, discusses how the emergence of CAR T-cell therapies have affected the treatment paradigms in various hematologic malignancies, expands on how persisting challenges with the use of this type of treatment are being addressed, and details research into the use of CAR T-cell therapy in patients with solid tumors. ....

United States , Mark Leick , Groupc Monthly , Harvard Medical School , Research Institute , Mass General Research Institute , Massachusetts General Hospital , Cart Cell Therapy , Solid Tumors , Hematologic Malignancies ,